Ovoca Bio Plc is a clinical-stage biopharmaceutical company, which engages in the women's health, clinical development and commercial planning of BP-101, and novel treatment for women with hypoactive sexual desire disorder (HSDD). It operates through the following segments: Bio-pharmaceutical, Investment, and Administrative. The Bio-pharmaceutical segment covers activities that are carried out by IVIX LLC and OVB Australia Pty. The Investment segment represents activities carried out by Silver Star Limited, a subsidiary company located in Bermuda. The Administrative segment consists of the group administration costs. The company was founded on January 15, 1985 and is headquartered in Dublin, Ireland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company